CINA-LVO

Avicenna.AI

The CINA-LVO solution is designed to automatically detect and prioritize acute large vessel occlusions on CTA.

Product specifications

Information source: Vendor
Last updated: Aug. 17, 2023

General
Product name	CINA-LVO
Company	Avicenna.AI
Subspeciality	Neuro
Modality	CT
Disease targeted	Stroke
Key-features	Large vessel occlusion detection, notification
Suggested use	Before: adapting worklist order, flagging acute findings
Data characteristics
Population	Suspicion of stroke
Input	Brain CTA
Input format	DICOM
Output	bounding box, worklist order, notification
Output format	DICOM SC, GSPS
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis	Automatically, right after the image acquisition
Processing time	10 - 60 seconds
Certification
CE	Certified, Class I , MDD
FDA	510(k) cleared, Class II
Market presence
On market since	02-2020
Distribution channels	Eureka Clinical AI, Canon Automation Platform, Blackford, Tempus Pixel, Nuance PIN AI Marketplace, Sectra Amplifier Store, deepcOS, Incepto, CARPL.ai, Calantic
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance	Duration and accuracy of automated stroke CT workflow with AI‑supported intracranial large vessel occlusion detection (read) Validation of an artificial intelligence-driven large vessel occlusion detection algorithm for acute ischemic stroke patients (read) Validation of a Deep Learning Tool in the Detection of Intracranial Hemorrhage and Large Vessel Occlusion (read)
Non-peer reviewed papers on performance
Other relevant papers